Pacira BioSciences
PCRX
PCRX
248 hedge funds and large institutions have $2.56B invested in Pacira BioSciences in 2020 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 88 increasing their positions, 72 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 226 → 248 (+22)
3.73% more ownership
Funds ownership: 111.93% → 115.66% (+3.7%)
35% less call options, than puts
Call options by funds: $6.23M | Put options by funds: $9.59M
Holders
248
Holding in Top 10
7
Calls
$6.23M
Puts
$9.59M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$19.6M | |
| 3 | +$19M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$18.9M |
| 5 |
SCM
Spyglass Capital Management
San Francisco,
California
|
+$17.9M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$22.4M | |
| 3 | -$11.2M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$10M |
| 5 |
Millennium Management
New York
|
-$8.62M |